- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有105家主力机构披露2025-06-30报告期持股数据，持仓量总计9269.01万股，占流通A股11.02%
- 波段诊断：
-
技术面诊股
诊断结果：5.2技术面打败了60%的股票
技术面评分前10的股票
近期的平均成本为11.92元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为11.92元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"11.92","date":1765785446,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑赢行业平均水平。
[{"date":"2025.12.16","stock":"-2.55","trade":"-2.00","ind":"-1.51"},{"date":"2025.12.15","stock":"-1.30","trade":"-1.10","ind":"-1.10"},{"date":"2025.12.12","stock":"-0.08","trade":"-0.50","ind":"0.84"},{"date":"2025.12.11","stock":"-0.32","trade":"-0.87","ind":"-1.27"},{"date":"2025.12.10","stock":"-0.24","trade":"-0.07","ind":"0.29"},{"date":"2025.12.09","stock":"-1.74","trade":"-1.51","ind":"-0.39"},{"date":"2025.12.08","stock":"-0.39","trade":"0.25","ind":"1.39"},{"date":"2025.12.05","stock":"-1.33","trade":"0.10","ind":"1.08"},{"date":"2025.12.04","stock":"-0.23","trade":"-0.40","ind":"0.40"},{"date":"2025.12.03","stock":"6.11","trade":"-0.45","ind":"-0.78"},{"date":"2025.12.02","stock":"-1.30","trade":"-1.08","ind":"-0.68"},{"date":"2025.12.01","stock":"1.24","trade":"0.07","ind":"1.25"},{"date":"2025.11.28","stock":"-1.06","trade":"-0.17","ind":"0.85"},{"date":"2025.11.27","stock":"0.08","trade":"-0.20","ind":"-0.25"},{"date":"2025.11.26","stock":"-0.16","trade":"1.10","ind":"1.02"},{"date":"2025.11.25","stock":"1.24","trade":"2.23","ind":"1.53"},{"date":"2025.11.24","stock":"2.11","trade":"1.45","ind":"0.37"},{"date":"2025.11.21","stock":"-3.02","trade":"-3.83","ind":"-3.41"},{"date":"2025.11.20","stock":"-1.61","trade":"-0.26","ind":"-0.76"},{"date":"2025.11.19","stock":"-1.82","trade":"-1.93","ind":"-0.00"},{"date":"2025.11.18","stock":"-0.86","trade":"-1.16","ind":"-0.92"}]
亿帆医药,深证成指,化学制药指数
压力支撑
该股压力位为11.98元，支撑位为11.77元。
[{"text":"\u538b\u529b\u4f4d","value":"11.98","date":1765814400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"11.77","date":1765814400,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.3资金面打败了15%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：12月16日 20:30
| 机构今日流向(万元) | -1711.06 | 机构5日流向(万元) | -4641.23 |
| 机构10日流向(万元) | -9667.12 | 机构20日流向(万元) | -19551.11 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少978.78万股，其中基金净减仓24家，主力净减仓110家，请投资者中长期谨慎为宜。
截止2025-06-30，共105家主力机构（基金100家，一般法人5家），持仓量总计9269.01万股，占流通A股11.02%
其中，基金持仓与2024-12-31相比：
增仓：10家 ，增持 14.93万股
减仓：34家 ，减持 521.56万股
新出现在主力名单中：54家 ，持有2895.46万股
从主力名单中消失：164家 ，原持有3514.4万股
其中，基金持仓与2024-12-31相比：
增仓：10家 ，增持 14.93万股
减仓：34家 ，减持 521.56万股
新出现在主力名单中：54家 ，持有2895.46万股
从主力名单中消失：164家 ，原持有3514.4万股
消息面诊股
诊断结果：5.5消息面打败了11%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 亿帆医药：12月15日获融资买入808.16万元
2025-12-16 - 亿帆医药王峰：通过全球商业化反哺创新、反哺中国市场
2025-12-12 - 首版商保创新药目录发布：阿尔茨海默病新药纳入 肿瘤
2025-12-10 - 亿帆医药：3款产品入围医保目录
2025-12-09 - 亿帆医药全资子公司部分产品获批开展临床试验
2025-12-09 - 亿帆医药：子公司N-3C01注射液临床试验获批
2025-12-08 - 亿帆医药：公司产品被纳入2025年国家医保目录
2025-12-08 - 亿帆医药：罕见病类产品销售额目前占比低于5%
2025-12-05 - 亿帆医药调剂子公司担保额度 并新增5.1亿元担保
2025-12-05 - 亿帆医药：公司产品2’-岩藻糖基乳糖获批
2025-12-05
消息列表
| 一般消息 | 高管变动 | 离任 | 2025-09-05 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-15 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-15 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-07 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-28 |
| 一般消息 | 募资投向 | 2025-05-08 | |
| 利好 | 分红转增 | 10派1元(含税) | 2025-04-28 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-02-21 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-02-07 |
| 利好 | 业绩预告 | 预计扭亏 | 2025-01-24 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.0行业面打败了71%的股票
化学制药行业最新资金流向
近10日来该行业走势总体向下，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，明显跑输大盘。
[{"date":"2025.12.16","price":"-1.51","value":"-2.00"},{"date":"2025.12.15","price":"-1.10","value":"-1.10"},{"date":"2025.12.12","price":"0.84","value":"-0.50"},{"date":"2025.12.11","price":"-1.27","value":"-0.87"},{"date":"2025.12.10","price":"0.29","value":"-0.07"},{"date":"2025.12.09","price":"-0.39","value":"-1.51"},{"date":"2025.12.08","price":"1.39","value":"0.25"},{"date":"2025.12.05","price":"1.08","value":"0.10"},{"date":"2025.12.04","price":"0.40","value":"-0.40"},{"date":"2025.12.03","price":"-0.78","value":"-0.45"},{"date":"2025.12.02","price":"-0.68","value":"-1.08"},{"date":"2025.12.01","price":"1.25","value":"0.07"},{"date":"2025.11.28","price":"0.85","value":"-0.17"},{"date":"2025.11.27","price":"-0.25","value":"-0.20"},{"date":"2025.11.26","price":"1.02","value":"1.10"},{"date":"2025.11.25","price":"1.53","value":"2.23"},{"date":"2025.11.24","price":"0.37","value":"1.45"},{"date":"2025.11.21","price":"-3.41","value":"-3.83"},{"date":"2025.11.20","price":"-0.76","value":"-0.26"},{"date":"2025.11.19","price":"-0.00","value":"-1.93"},{"date":"2025.11.18","price":"-0.92","value":"-1.16"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 益方生物 | 11.51% | 3.76% | 6.1分 |
| 2 | 海创药业 | 9.44% | -6.69% | 5.6分 |
| 3 | 常山药业 | 8.87% | -3.73% | 5.2分 |
| 4 | 前沿生物 | 8.37% | -1.14% | 5.3分 |
| 5 | 悦康药业 | 7.51% | -8.11% | 5.2分 |
| 6 | 花园生物 | 7.27% | 4.95% | 6.1分 |
| 8 | 普洛药业 | 4.42% | 0.82% | 6.1分 |
| 10 | 艾力斯 | 2.41% | 2.12% | 5.3分 |
| 12 | 恩华药业 | 1.69% | 0.86% | 5.8分 |
| 14 | 福元医药 | 0.69% | -2.50% | 5.7分 |
| 16 | 河化股份 | 0.00% | -5.58% | 4.8分 |
| 18 | 天新药业 | -1.03% | 0.80% | 5.3分 |
| 20 | 国药现代 | -2.96% | -0.20% | 5.8分 |
| 22 | 新和成 | -3.43% | -0.91% | 5.4分 |
| 24 | 微芯生物 | -4.26% | -3.71% | 5.1分 |
| 26 | 华润双鹤 | -4.36% | -2.31% | 5.1分 |
| 28 | 亚虹医药 | -4.57% | -2.10% | 5.0分 |
| 30 | 泽璟制药 | -4.73% | -10.05% | 5.1分 |
| 32 | 海欣股份 | -4.84% | -8.24% | 4.9分 |
| 34 | - | -5.06% | 3.01% | 分 |
| 36 | 山河药辅 | -5.28% | -5.28% | 3.9分 |
| 38 | 浙江医药 | -5.44% | -2.16% | 5.0分 |
| 40 | 吉贝尔 | -5.65% | -3.45% | 5.5分 |
| 42 | 多瑞医药 | -5.94% | -8.88% | 4.3分 |
| 44 | 金陵药业 | -6.02% | -5.11% | 5.7分 |
| 46 | 哈药股份 | -6.13% | -3.30% | 4.7分 |
| 48 | - | -6.26% | 4.23% | 分 |
| 50 | ST复华 | -6.45% | -2.75% | 4.3分 |
| 52 | 华东医药 | -6.68% | -5.68% | 5.2分 |
| 54 | 通化金马 | -6.81% | -3.14% | 4.9分 |
| 56 | - | -6.97% | 2.18% | 分 |
| 58 | 博瑞医药 | -7.06% | -6.05% | 4.5分 |
| 60 | 新华制药 | -7.09% | -6.25% | 4.9分 |
| 62 | 广济药业 | -7.48% | -9.13% | 4.7分 |
| 64 | 百利天恒 | -7.57% | -4.06% | 4.5分 |
| 66 | 复旦张江 | -7.75% | -2.73% | 4.5分 |
| 68 | 华邦健康 | -7.89% | -2.51% | 5.0分 |
| 70 | 美诺华 | -8.23% | -3.82% | 5.0分 |
| 72 | 奥赛康 | -8.43% | -4.79% | 4.7分 |
| 74 | 九典制药 | -8.60% | -4.58% | 3.5分 |
| 76 | 东北制药 | -8.77% | -4.41% | 5.3分 |
| 78 | 海翔药业 | -8.87% | -8.15% | 4.1分 |
| 80 | *ST景峰 | -8.88% | 1.04% | 4.6分 |
| 82 | - | -9.02% | 0.58% | 分 |
| 84 | 海森药业 | -9.43% | -5.45% | 4.4分 |
| 86 | 京新药业 | -9.47% | -0.53% | 5.1分 |
| 88 | - | -9.66% | 3.45% | 分 |
| 90 | 汉商集团 | -10.08% | -4.07% | 5.1分 |
| 92 | - | -10.14% | 2.34% | 分 |
| 94 | 易明医药 | -10.22% | -2.00% | 4.2分 |
| 96 | 华仁药业 | -10.45% | -6.49% | 5.0分 |
| 98 | 神奇制药 | -10.66% | -7.97% | 5.4分 |
| 100 | 川宁生物 | -10.89% | -4.38% | 3.7分 |
| 102 | 海南海药 | -11.12% | -9.08% | 4.7分 |
| 104 | 泰恩康 | -11.34% | -1.49% | 4.0分 |
| 106 | 罗欣药业 | -11.41% | -5.60% | 4.2分 |
| 108 | 中关村 | -11.60% | -6.25% | 4.7分 |
| 110 | 北陆药业 | -11.81% | -5.30% | 4.2分 |
| 112 | 贝达药业 | -12.18% | -5.56% | 4.4分 |
| 114 | 鲁抗医药 | -12.24% | -4.31% | 4.6分 |
| 116 | 首药控股 | -12.33% | -5.56% | 3.8分 |
| 118 | 盟科药业 | -12.61% | -3.25% | 4.5分 |
| 120 | 仟源医药 | -12.78% | -3.91% | 4.8分 |
| 122 | 新天地 | -12.95% | -3.39% | 4.3分 |
| 124 | 德展健康 | -13.18% | -2.80% | 3.8分 |
| 126 | 莱美药业 | -13.22% | -7.17% | 3.7分 |
| 128 | 广生堂 | -13.30% | -8.92% | 3.5分 |
| 130 | 尔康制药 | -13.92% | -6.85% | 4.1分 |
| 132 | 溢多利 | -14.23% | -6.77% | 3.5分 |
| 134 | ST天圣 | -14.36% | -6.55% | 4.0分 |
| 136 | ST人福 | -15.03% | -6.86% | 4.4分 |
| 138 | 南新制药 | -16.20% | -7.13% | 4.2分 |
| 140 | 科源制药 | -16.34% | -4.86% | 3.6分 |
| 142 | 金城医药 | -16.46% | -8.57% | 4.2分 |
| 144 | 纳微科技 | -16.77% | -3.25% | 5.9分 |
| 146 | 宏源药业 | -17.04% | -4.76% | 3.5分 |
| 148 | 赛分科技 | -17.94% | -4.41% | 4.8分 |
| 150 | 民生健康 | -18.23% | -6.80% | 4.1分 |
| 152 | 昂利康 | -21.52% | -12.65% | 4.7分 |
| 154 | 富祥药业 | -22.18% | -2.98% | 3.7分 |
| 156 | 海辰药业 | -24.57% | -6.44% | 3.9分 |
| 158 | 退市苏吴 | -65.00% | -12.50% | 4.6分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 68/219 ， 78/219。
[{"date":"2025-09-30","value":"4.47","vol":"1.46"},{"date":"2025-06-30","value":"3.51","vol":"1.21"},{"date":"2025-03-31","value":"1.78","vol":"-0.17"},{"date":"2024-12-31","value":"4.60","vol":"19.51"},{"date":"2024-09-30","value":"4.36","vol":"4.61"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.47 | 3.51 | 1.78 | 4.60 | 4.36 |
| 行业(%) | 1.46 | 1.21 | -0.17 | 19.51 | 4.61 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"47.82","vol":"49.47"},{"date":"2025-06-30","value":"48.57","vol":"49.43"},{"date":"2025-03-31","value":"46.39","vol":"49.23"},{"date":"2024-12-31","value":"47.42","vol":"50.77"},{"date":"2024-09-30","value":"47.65","vol":"50.51"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
47.82 | 48.57 | 46.39 | 47.42 | 47.65 |
| 行业(%) | 49.47 | 49.43 | 49.23 | 50.77 | 50.51 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 52/219 ， 63/219。
[{"date":"2025-09-30","value":"1.67","vol":"141.76"},{"date":"2025-06-30","value":"0.11","vol":"78.53"},{"date":"2025-03-31","value":"0.05","vol":"-0.84"},{"date":"2024-12-31","value":"26.84","vol":"17.76"},{"date":"2024-09-30","value":"31.67","vol":"45.69"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
1.67 | 0.11 | 0.05 | 26.84 | 31.67 |
| 行业(%) | 141.76 | 78.53 | -0.84 | 17.76 | 45.69 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"5.84","vol":"-5.21"},{"date":"2025-06-30","value":"19.91","vol":"56.29"},{"date":"2025-03-31","value":"4.83","vol":"-21.21"},{"date":"2024-12-31","value":"170.04","vol":"-20.55"},{"date":"2024-09-30","value":"149.50","vol":"-32.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
5.84 | 19.91 | 4.83 | 170.04 | 149.50 |
| 行业(%) | -5.21 | 56.29 | -21.21 | -20.55 | -32.33 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 63/219 ， 67/219。
[{"date":"2025-09-30","value":"0.31","vol":"0.31"},{"date":"2025-06-30","value":"0.21","vol":"0.21"},{"date":"2025-03-31","value":"0.11","vol":"0.10"},{"date":"2024-12-31","value":"0.43","vol":"0.43"},{"date":"2024-09-30","value":"0.32","vol":"0.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.31 | 0.21 | 0.11 | 0.43 | 0.32 |
| 行业(次) | 0.31 | 0.21 | 0.10 | 0.43 | 0.33 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.71","vol":"1.95"},{"date":"2025-06-30","value":"1.20","vol":"1.31"},{"date":"2025-03-31","value":"0.66","vol":"0.67"},{"date":"2024-12-31","value":"2.73","vol":"3.22"},{"date":"2024-09-30","value":"2.03","vol":"2.18"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.71 | 1.20 | 0.66 | 2.73 | 2.03 |
| 行业(次) | 1.95 | 1.31 | 0.67 | 3.22 | 2.18 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"3.11","vol":"4.36"},{"date":"2025-06-30","value":"7.93","vol":"2.81"},{"date":"2025-03-31","value":"13.74","vol":"-28.76"},{"date":"2024-12-31","value":"22.07","vol":"-371.46"},{"date":"2024-09-30","value":"17.10","vol":"-9.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 3.11 | 7.93 | 13.74 | 22.07 | 17.10 |
| 行业 | 4.36 | 2.81 | -28.76 | -371.46 | -9.87 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.31","vol":"1.72"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.82","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.31 | - | 1.82 | - |
| 行业 | 0.00 | 1.72 | 0.00 | 1.99 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 57/219 ， 22/219。
[{"date":"2025-09-30","value":"1.27","vol":"3.49"},{"date":"2025-06-30","value":"1.31","vol":"3.67"},{"date":"2025-03-31","value":"1.37","vol":"3.59"},{"date":"2024-12-31","value":"1.26","vol":"3.34"},{"date":"2024-09-30","value":"1.32","vol":"3.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.27 | 1.31 | 1.37 | 1.26 | 1.32 |
| 行业 | 3.49 | 3.67 | 3.59 | 3.34 | 3.66 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.80","vol":"2.74"},{"date":"2025-06-30","value":"0.83","vol":"2.89"},{"date":"2025-03-31","value":"0.89","vol":"2.81"},{"date":"2024-12-31","value":"0.83","vol":"2.64"},{"date":"2024-09-30","value":"0.88","vol":"2.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.80 | 0.83 | 0.89 | 0.83 | 0.88 |
| 行业 | 2.74 | 2.89 | 2.81 | 2.64 | 2.92 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 58/219 ， 69/219。
[{"date":"2025-09-30","value":"33.55","vol":"33.75"},{"date":"2025-06-30","value":"31.70","vol":"33.79"},{"date":"2025-03-31","value":"31.36","vol":"34.04"},{"date":"2024-12-31","value":"31.41","vol":"34.19"},{"date":"2024-09-30","value":"31.94","vol":"33.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
33.55 | 31.70 | 31.36 | 31.41 | 31.94 |
| 行业(%) | 33.75 | 33.79 | 34.04 | 34.19 | 33.02 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.50","vol":"0.94"},{"date":"2025-06-30","value":"0.46","vol":"0.88"},{"date":"2025-03-31","value":"0.45","vol":"1.46"},{"date":"2024-12-31","value":"0.45","vol":"0.84"},{"date":"2024-09-30","value":"0.46","vol":"0.73"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.50 | 0.46 | 0.45 | 0.45 | 0.46 |
| 行业(%) | 0.94 | 0.88 | 1.46 | 0.84 | 0.73 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"2.78","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"1.91","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-5.51","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"3.86","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"5.93","blueLineValue":"0.49","type":"YC"}]